Where we invest

Building on our accelerator partnerships and surgeon network, ASPS Ventures now deploys direct capital into breakthrough medtech, diagnostics, robotics, and regenerative technologies shaping the next decade of reconstructive and aesthetic surgery. In collaboration with leading venture capital and strategic partners, we identify, validate, and guide companies — driving innovation through strategic funding, clinical insight, and expert mentorship.

A man in a gray suit giving a presentation at a conference with a MedTech Innovator backdrop. He is holding a microphone and gesturing with his left hand.
Two men in suits standing together at an event, holding a large check for $10,000. One man is holding the check, and both are smiling. There is a banner behind them with the logo 'AdvaMed Advance' and text about advancing inclusion and diversity in medicine. The event is in a room with a blue door labeled '210C' and patterned carpet.
Logos of Medtech Innovator and American Society of Plastic Surgeons separated by a vertical line.

Portfolio Companies

ASPS / MedTech Innovator Plastic Surgery Accelerator Track Cohort Companies

Current 2026 Cohort

2026 MTI COHORT

2026 MTI COHORT

2026 MTI COHORT

2026 MTI COHORT

2026 MTI COHORT

Previous Cohorts

2025

ALUMNI

ALUMNI

ALUMNI

ALUMNI

ALUMNI

2024

ALUMNI

ALUMNI

ALUMNI

ALUMNI

ALUMNI

2023

ALUMNI

ALUMNI

ALUMNI

ALUMNI

ALUMNI

2022

ALUMNI

ALUMNI

ALUMNI

MTI Innovation Pipeline

Screening at Scale. Selecting the Best. Delivering Impact.

Presentation slide titled "MedTech Innovator/ASPS Plastic Surgery Accelerator Track" with logos of MedTech Innovator and American Society of Plastic Surgeons.
Presentation slide titled "MedTech Innovator/ASPS Plastic Surgery Accelerator Track" with logos of MedTech Innovator and American Society of Plastic Surgeons.

125+

Companies Screened Annually

5

Companies Selected Annually

18

Cohort Companies

Backed by ASPS clinical validation, mentorship and measurable outcomes.

150+

Patents Issued

$160 M+

Total Capital Raised

23+

Products Launched

100+

Peer-Reviewed Publications

50+

Animal Studies

2

Exits/Acquisitions

29+

Human Studies

$337,500+

MTI Competition Funding